Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
6 studies found for:    vorinostat, prostate
Show Display Options
Rank Status Study
1 Completed
Has Results
Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer
Conditions: Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: vorinostat;   Other: laboratory biomarker analysis
2 Completed Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
Conditions: Prostate Adenocarcinoma;   Stage I Prostate Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Goserelin Acetate;   Other: Laboratory Biomarker Analysis;   Drug: Leuprolide Acetate;   Procedure: Therapeutic Conventional Surgery;   Drug: Vorinostat
3 Terminated Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer;   Adenocarcinoma of the Prostate;   Hormone-resistant Prostate Cancer;   Recurrent Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Drug: vorinostat;   Drug: temsirolimus;   Other: laboratory biomarker analysis;   Procedure: positron emission tomography/computed tomography
4 Terminated Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies.
Conditions: Non-Small-Cell Lung Carcinoma;   Prostate Cancer;   Bladder Cancer;   Urothelial Carcinoma
Interventions: Drug: vorinostat (suberoylanilide hydroxamic acid);   Drug: docetaxel
5 Completed Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Prostate Cancer;   Small Intestine Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Drug: vorinostat
6 Completed Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
Condition: Cancer
Intervention: Drug: vorinostat

Study has passed its completion date and status has not been verified in more than two years.